Structure

Physi-Chem Properties

Molecular Weight:  402.17
Volume:  400.555
LogP:  2.686
LogD:  2.847
LogS:  -3.971
# Rotatable Bonds:  6
TPSA:  83.45
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.732
Synthetic Accessibility Score:  5.459
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.561
MDCK Permeability:  2.118169140885584e-05
Pgp-inhibitor:  0.09
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.075
30% Bioavailability (F30%):  0.175

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.575
Plasma Protein Binding (PPB):  84.02781677246094%
Volume Distribution (VD):  1.397
Pgp-substrate:  11.776191711425781%

ADMET: Metabolism

CYP1A2-inhibitor:  0.084
CYP1A2-substrate:  0.985
CYP2C19-inhibitor:  0.031
CYP2C19-substrate:  0.853
CYP2C9-inhibitor:  0.017
CYP2C9-substrate:  0.204
CYP2D6-inhibitor:  0.499
CYP2D6-substrate:  0.426
CYP3A4-inhibitor:  0.921
CYP3A4-substrate:  0.805

ADMET: Excretion

Clearance (CL):  8.576
Half-life (T1/2):  0.38

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.104
Drug-inuced Liver Injury (DILI):  0.121
AMES Toxicity:  0.233
Rat Oral Acute Toxicity:  0.908
Maximum Recommended Daily Dose:  0.764
Skin Sensitization:  0.41
Carcinogencity:  0.949
Eye Corrosion:  0.005
Eye Irritation:  0.018
Respiratory Toxicity:  0.981

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476244

Natural Product ID:  NPC476244
Common Name*:   Cinerin D
IUPAC Name:   (1R,4S,5S,6S,7R)-4-hydroxy-1,5-dimethoxy-6-(7-methoxy-1,3-benzodioxol-5-yl)-7-methyl-3-prop-2-enylbicyclo[3.2.1]oct-2-en-8-one
Synonyms:   Cinerin D
Standard InCHIKey:  XLIOFFLNGANYEP-RDKBRGHYSA-N
Standard InCHI:  InChI=1S/C22H26O7/c1-6-7-13-10-21(26-4)12(2)17(22(27-5,19(13)23)20(21)24)14-8-15(25-3)18-16(9-14)28-11-29-18/h6,8-10,12,17,19,23H,1,7,11H2,2-5H3/t12-,17+,19+,21+,22+/m1/s1
SMILES:  CC1C(C2(C(C(=CC1(C2=O)OC)CC=C)O)OC)C3=CC4=C(C(=C3)OC)OCO4
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL558110
PubChem CID:   45273291
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000296] Benzodioxoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19526 Pleurothyrium cinereum Species Lauraceae Eukaryota leaves n.a. n.a. PMID[19548690]
NPO26326 Ocotea macrophylla Species Lauraceae Eukaryota leaves n.a. n.a. PMID[19880317]
NPO27964 Nectandra amazonum Species Lauraceae Eukaryota leaves n.a. n.a. PMID[19880317]
NPO19526 Pleurothyrium cinereum Species Lauraceae Eukaryota leaves n.a. n.a. PMID[19880317]
NPO26326 Ocotea macrophylla Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27964 Nectandra amazonum Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT324 Individual Protein Cyclooxygenase-1 Ovis aries IC50 = 188000.0 nM PMID[542571]
NPT325 Individual Protein Cyclooxygenase-2 Ovis aries IC50 = 92100.0 nM PMID[542571]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 6600.0 nM PMID[542570]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis GI = 7.3 % PMID[542570]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis GI = 6.2 % PMID[542570]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis GI = 1.3 % PMID[542570]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 17.0 % PMID[542570]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus GI < 30.0 % PMID[542570]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis GI < 30.0 % PMID[542570]
NPT19 Organism Escherichia coli Escherichia coli GI < 30.0 % PMID[542570]
NPT1117 Organism Salmonella enterica subsp. enterica Salmonella enterica subsp. enterica GI < 30.0 % PMID[542570]
NPT2 Others Unspecified IC50 = 8840.0 nM PMID[542571]
NPT2 Others Unspecified Ratio IC50 = 2.04 n.a. PMID[542571]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 6630.0 nM PMID[542571]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 25600.0 nM PMID[542571]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 356000.0 nM PMID[542571]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476244 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9557 High Similarity NPC476277
0.9412 High Similarity NPC28724
0.9241 High Similarity NPC476337
0.9114 High Similarity NPC476340
0.8987 High Similarity NPC476363
0.8924 High Similarity NPC476364
0.8797 High Similarity NPC476335
0.8704 High Similarity NPC472565
0.8698 High Similarity NPC23593
0.8639 High Similarity NPC107739
0.8608 High Similarity NPC472567
0.8596 High Similarity NPC236089
0.8589 High Similarity NPC475095
0.8588 High Similarity NPC263955
0.8538 High Similarity NPC29587
0.85 High Similarity NPC163002
0.8481 Intermediate Similarity NPC476338
0.8481 Intermediate Similarity NPC476359
0.8481 Intermediate Similarity NPC476336
0.8452 Intermediate Similarity NPC476334
0.8447 Intermediate Similarity NPC56184
0.8438 Intermediate Similarity NPC475170
0.8438 Intermediate Similarity NPC177830
0.8418 Intermediate Similarity NPC476362
0.8344 Intermediate Similarity NPC136757
0.8313 Intermediate Similarity NPC304821
0.8303 Intermediate Similarity NPC220462
0.8302 Intermediate Similarity NPC472560
0.8274 Intermediate Similarity NPC469475
0.8274 Intermediate Similarity NPC469518
0.8261 Intermediate Similarity NPC477698
0.825 Intermediate Similarity NPC25496
0.8242 Intermediate Similarity NPC189730
0.8221 Intermediate Similarity NPC477699
0.8214 Intermediate Similarity NPC125991
0.821 Intermediate Similarity NPC12854
0.8204 Intermediate Similarity NPC310399
0.8204 Intermediate Similarity NPC73422
0.8198 Intermediate Similarity NPC271755
0.8198 Intermediate Similarity NPC254071
0.8198 Intermediate Similarity NPC149502
0.8198 Intermediate Similarity NPC222665
0.8187 Intermediate Similarity NPC474799
0.8182 Intermediate Similarity NPC164152
0.8176 Intermediate Similarity NPC15743
0.8171 Intermediate Similarity NPC244903
0.8171 Intermediate Similarity NPC245948
0.8171 Intermediate Similarity NPC327225
0.8161 Intermediate Similarity NPC156635
0.816 Intermediate Similarity NPC234152
0.816 Intermediate Similarity NPC164082
0.8155 Intermediate Similarity NPC90336
0.8148 Intermediate Similarity NPC145569
0.8148 Intermediate Similarity NPC216223
0.8144 Intermediate Similarity NPC209473
0.8144 Intermediate Similarity NPC329743
0.8144 Intermediate Similarity NPC179914
0.8133 Intermediate Similarity NPC32373
0.8133 Intermediate Similarity NPC237946
0.8129 Intermediate Similarity NPC174191
0.8125 Intermediate Similarity NPC474982
0.8121 Intermediate Similarity NPC25127
0.8118 Intermediate Similarity NPC475738
0.8113 Intermediate Similarity NPC474966
0.811 Intermediate Similarity NPC151425
0.8107 Intermediate Similarity NPC469512
0.8101 Intermediate Similarity NPC51681
0.8095 Intermediate Similarity NPC91634
0.8095 Intermediate Similarity NPC268718
0.8095 Intermediate Similarity NPC150943
0.8092 Intermediate Similarity NPC245452
0.8092 Intermediate Similarity NPC469506
0.8084 Intermediate Similarity NPC19947
0.8084 Intermediate Similarity NPC474990
0.8084 Intermediate Similarity NPC207584
0.8081 Intermediate Similarity NPC476771
0.8072 Intermediate Similarity NPC38699
0.807 Intermediate Similarity NPC254306
0.807 Intermediate Similarity NPC67037
0.807 Intermediate Similarity NPC255615
0.807 Intermediate Similarity NPC113093
0.807 Intermediate Similarity NPC475621
0.8063 Intermediate Similarity NPC27159
0.8063 Intermediate Similarity NPC50696
0.8061 Intermediate Similarity NPC473236
0.8059 Intermediate Similarity NPC471286
0.8059 Intermediate Similarity NPC472582
0.8059 Intermediate Similarity NPC475865
0.805 Intermediate Similarity NPC104956
0.8049 Intermediate Similarity NPC62354
0.8049 Intermediate Similarity NPC178048
0.8047 Intermediate Similarity NPC288149
0.8038 Intermediate Similarity NPC203351
0.8037 Intermediate Similarity NPC477695
0.8037 Intermediate Similarity NPC125570
0.8037 Intermediate Similarity NPC174512
0.8037 Intermediate Similarity NPC668
0.8037 Intermediate Similarity NPC293757
0.8037 Intermediate Similarity NPC474965
0.8036 Intermediate Similarity NPC477410
0.8036 Intermediate Similarity NPC76211
0.8035 Intermediate Similarity NPC212748
0.8035 Intermediate Similarity NPC72249
0.8025 Intermediate Similarity NPC474039
0.8025 Intermediate Similarity NPC30720
0.8024 Intermediate Similarity NPC164244
0.8023 Intermediate Similarity NPC42892
0.8023 Intermediate Similarity NPC42230
0.8023 Intermediate Similarity NPC48640
0.8023 Intermediate Similarity NPC474948
0.8023 Intermediate Similarity NPC283041
0.8023 Intermediate Similarity NPC149244
0.8023 Intermediate Similarity NPC471180
0.8012 Intermediate Similarity NPC34531
0.8012 Intermediate Similarity NPC287504
0.8011 Intermediate Similarity NPC67302
0.8 Intermediate Similarity NPC108202
0.8 Intermediate Similarity NPC76687
0.8 Intermediate Similarity NPC196937
0.8 Intermediate Similarity NPC472564
0.8 Intermediate Similarity NPC474808
0.8 Intermediate Similarity NPC476011
0.7989 Intermediate Similarity NPC223375
0.7989 Intermediate Similarity NPC235575
0.7989 Intermediate Similarity NPC471181
0.7989 Intermediate Similarity NPC475825
0.7989 Intermediate Similarity NPC261254
0.7989 Intermediate Similarity NPC470685
0.7989 Intermediate Similarity NPC476772
0.7988 Intermediate Similarity NPC269906
0.7988 Intermediate Similarity NPC96593
0.7988 Intermediate Similarity NPC119910
0.7988 Intermediate Similarity NPC474936
0.7987 Intermediate Similarity NPC470991
0.7977 Intermediate Similarity NPC223747
0.7977 Intermediate Similarity NPC225434
0.7977 Intermediate Similarity NPC203050
0.7977 Intermediate Similarity NPC120099
0.7977 Intermediate Similarity NPC52382
0.7977 Intermediate Similarity NPC270578
0.7977 Intermediate Similarity NPC219904
0.7976 Intermediate Similarity NPC473395
0.7976 Intermediate Similarity NPC286919
0.7976 Intermediate Similarity NPC475663
0.7965 Intermediate Similarity NPC20237
0.7964 Intermediate Similarity NPC267242
0.7963 Intermediate Similarity NPC212890
0.7963 Intermediate Similarity NPC87295
0.7963 Intermediate Similarity NPC212697
0.7963 Intermediate Similarity NPC3982
0.7956 Intermediate Similarity NPC71385
0.7956 Intermediate Similarity NPC230670
0.7953 Intermediate Similarity NPC14294
0.7953 Intermediate Similarity NPC116759
0.7952 Intermediate Similarity NPC474514
0.7952 Intermediate Similarity NPC35544
0.7952 Intermediate Similarity NPC104728
0.7944 Intermediate Similarity NPC475360
0.7943 Intermediate Similarity NPC474568
0.7941 Intermediate Similarity NPC100465
0.7941 Intermediate Similarity NPC295009
0.7941 Intermediate Similarity NPC94155
0.7941 Intermediate Similarity NPC260640
0.7941 Intermediate Similarity NPC117985
0.7941 Intermediate Similarity NPC152424
0.7939 Intermediate Similarity NPC477700
0.7937 Intermediate Similarity NPC287124
0.7937 Intermediate Similarity NPC210354
0.7937 Intermediate Similarity NPC176586
0.7931 Intermediate Similarity NPC477883
0.7931 Intermediate Similarity NPC206123
0.7931 Intermediate Similarity NPC279209
0.7931 Intermediate Similarity NPC102277
0.7929 Intermediate Similarity NPC469384
0.7929 Intermediate Similarity NPC215375
0.7929 Intermediate Similarity NPC62518
0.7927 Intermediate Similarity NPC474903
0.7925 Intermediate Similarity NPC322021
0.7925 Intermediate Similarity NPC470855
0.7925 Intermediate Similarity NPC147379
0.7925 Intermediate Similarity NPC177868
0.7921 Intermediate Similarity NPC170203
0.7921 Intermediate Similarity NPC6709
0.7919 Intermediate Similarity NPC265530
0.7919 Intermediate Similarity NPC76482
0.7919 Intermediate Similarity NPC84362
0.7919 Intermediate Similarity NPC150131
0.7919 Intermediate Similarity NPC226304
0.7919 Intermediate Similarity NPC173637
0.7919 Intermediate Similarity NPC92565
0.7919 Intermediate Similarity NPC223424
0.7919 Intermediate Similarity NPC317489
0.7919 Intermediate Similarity NPC160156
0.7919 Intermediate Similarity NPC127546
0.7919 Intermediate Similarity NPC52550
0.7919 Intermediate Similarity NPC325555
0.7917 Intermediate Similarity NPC155063
0.7917 Intermediate Similarity NPC163635
0.7917 Intermediate Similarity NPC478055
0.7914 Intermediate Similarity NPC208507

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476244 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8383 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8263 Intermediate Similarity NPD7199 Phase 2
0.8171 Intermediate Similarity NPD37 Approved
0.8133 Intermediate Similarity NPD4967 Phase 2
0.8133 Intermediate Similarity NPD4966 Approved
0.8133 Intermediate Similarity NPD4965 Approved
0.8036 Intermediate Similarity NPD6234 Discontinued
0.7919 Intermediate Similarity NPD3818 Discontinued
0.7865 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD7028 Phase 2
0.7816 Intermediate Similarity NPD7228 Approved
0.7811 Intermediate Similarity NPD3882 Suspended
0.7797 Intermediate Similarity NPD7808 Phase 3
0.7784 Intermediate Similarity NPD6797 Phase 2
0.774 Intermediate Similarity NPD7251 Discontinued
0.7727 Intermediate Similarity NPD7074 Phase 3
0.7697 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD7054 Approved
0.7647 Intermediate Similarity NPD3817 Phase 2
0.764 Intermediate Similarity NPD7685 Pre-registration
0.7633 Intermediate Similarity NPD1934 Approved
0.7627 Intermediate Similarity NPD7472 Approved
0.76 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD6166 Phase 2
0.7588 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3787 Discontinued
0.7576 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD7240 Approved
0.7516 Intermediate Similarity NPD3027 Phase 3
0.7514 Intermediate Similarity NPD3751 Discontinued
0.7471 Intermediate Similarity NPD5494 Approved
0.7457 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6002 Phase 3
0.7423 Intermediate Similarity NPD6004 Phase 3
0.7423 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6005 Phase 3
0.7384 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD2801 Approved
0.736 Intermediate Similarity NPD7473 Discontinued
0.7356 Intermediate Similarity NPD7075 Discontinued
0.7348 Intermediate Similarity NPD6559 Discontinued
0.7326 Intermediate Similarity NPD6801 Discontinued
0.7317 Intermediate Similarity NPD5762 Approved
0.7317 Intermediate Similarity NPD5763 Approved
0.7314 Intermediate Similarity NPD919 Approved
0.731 Intermediate Similarity NPD4380 Phase 2
0.7288 Intermediate Similarity NPD6232 Discontinued
0.7278 Intermediate Similarity NPD1512 Approved
0.7262 Intermediate Similarity NPD6799 Approved
0.7232 Intermediate Similarity NPD1247 Approved
0.7222 Intermediate Similarity NPD6355 Discontinued
0.7219 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD6599 Discontinued
0.7182 Intermediate Similarity NPD5844 Phase 1
0.7181 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6653 Approved
0.716 Intermediate Similarity NPD1511 Approved
0.7143 Intermediate Similarity NPD6190 Approved
0.7135 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD7799 Discontinued
0.7118 Intermediate Similarity NPD2532 Approved
0.7118 Intermediate Similarity NPD2533 Approved
0.7118 Intermediate Similarity NPD2534 Approved
0.7115 Intermediate Similarity NPD3705 Approved
0.7107 Intermediate Similarity NPD5647 Approved
0.7102 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD1653 Approved
0.7086 Intermediate Similarity NPD5761 Phase 2
0.7086 Intermediate Similarity NPD5760 Phase 2
0.7066 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8434 Phase 2
0.7056 Intermediate Similarity NPD3926 Phase 2
0.7055 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD3620 Phase 2
0.7055 Intermediate Similarity NPD1613 Approved
0.7055 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD5402 Approved
0.7039 Intermediate Similarity NPD8127 Discontinued
0.7037 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD1357 Approved
0.7011 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.699 Remote Similarity NPD7680 Approved
0.6989 Remote Similarity NPD7819 Suspended
0.6988 Remote Similarity NPD1510 Phase 2
0.6988 Remote Similarity NPD7033 Discontinued
0.6982 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6982 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6982 Remote Similarity NPD4110 Phase 3
0.6973 Remote Similarity NPD6765 Approved
0.6973 Remote Similarity NPD6764 Approved
0.6951 Remote Similarity NPD1240 Approved
0.6949 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6099 Approved
0.6946 Remote Similarity NPD6100 Approved
0.6936 Remote Similarity NPD5403 Approved
0.6923 Remote Similarity NPD6674 Discontinued
0.6923 Remote Similarity NPD2800 Approved
0.6919 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6911 Remote Similarity NPD7296 Approved
0.6909 Remote Similarity NPD230 Phase 1
0.6905 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6905 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6895 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6882 Remote Similarity NPD4628 Phase 3
0.6882 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1607 Approved
0.6864 Remote Similarity NPD1549 Phase 2
0.6848 Remote Similarity NPD4060 Phase 1
0.6845 Remote Similarity NPD2796 Approved
0.6837 Remote Similarity NPD6781 Approved
0.6837 Remote Similarity NPD6778 Approved
0.6837 Remote Similarity NPD6782 Approved
0.6837 Remote Similarity NPD6776 Approved
0.6837 Remote Similarity NPD6780 Approved
0.6837 Remote Similarity NPD6779 Approved
0.6837 Remote Similarity NPD6777 Approved
0.6831 Remote Similarity NPD2403 Approved
0.6829 Remote Similarity NPD6798 Discontinued
0.6825 Remote Similarity NPD6784 Approved
0.6825 Remote Similarity NPD6785 Approved
0.6821 Remote Similarity NPD5401 Approved
0.6818 Remote Similarity NPD7435 Discontinued
0.6813 Remote Similarity NPD7229 Phase 3
0.681 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6798 Remote Similarity NPD8455 Phase 2
0.6792 Remote Similarity NPD1091 Approved
0.679 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6788 Remote Similarity NPD6233 Phase 2
0.6786 Remote Similarity NPD651 Clinical (unspecified phase)
0.678 Remote Similarity NPD7411 Suspended
0.6778 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6766 Remote Similarity NPD6651 Approved
0.6761 Remote Similarity NPD7458 Discontinued
0.6758 Remote Similarity NPD6959 Discontinued
0.6748 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6747 Remote Similarity NPD943 Approved
0.6747 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6746 Remote Similarity NPD2935 Discontinued
0.6727 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6724 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6717 Remote Similarity NPD2494 Approved
0.6717 Remote Similarity NPD2493 Approved
0.6708 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6707 Remote Similarity NPD5735 Approved
0.6706 Remote Similarity NPD7266 Discontinued
0.6705 Remote Similarity NPD7236 Approved
0.6704 Remote Similarity NPD1465 Phase 2
0.67 Remote Similarity NPD4583 Approved
0.67 Remote Similarity NPD4582 Approved
0.6684 Remote Similarity NPD2974 Approved
0.6684 Remote Similarity NPD2975 Approved
0.6684 Remote Similarity NPD2973 Approved
0.6667 Remote Similarity NPD7095 Approved
0.6667 Remote Similarity NPD4580 Approved
0.6667 Remote Similarity NPD2424 Discontinued
0.6667 Remote Similarity NPD5353 Approved
0.6667 Remote Similarity NPD5958 Discontinued
0.665 Remote Similarity NPD7698 Approved
0.665 Remote Similarity NPD7696 Phase 3
0.665 Remote Similarity NPD7930 Approved
0.665 Remote Similarity NPD4004 Approved
0.665 Remote Similarity NPD7697 Approved
0.665 Remote Similarity NPD4002 Approved
0.6648 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6648 Remote Similarity NPD920 Approved
0.6647 Remote Similarity NPD4140 Approved
0.6646 Remote Similarity NPD2861 Phase 2
0.6646 Remote Similarity NPD3018 Phase 2
0.6646 Remote Similarity NPD9494 Approved
0.6646 Remote Similarity NPD1608 Approved
0.6645 Remote Similarity NPD5283 Phase 1
0.6633 Remote Similarity NPD3450 Approved
0.6633 Remote Similarity NPD3452 Approved
0.6632 Remote Similarity NPD8312 Approved
0.6632 Remote Similarity NPD8313 Approved
0.663 Remote Similarity NPD5710 Approved
0.663 Remote Similarity NPD5711 Approved
0.6629 Remote Similarity NPD3146 Approved
0.6629 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6627 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6626 Remote Similarity NPD6362 Approved
0.6626 Remote Similarity NPD3094 Phase 2
0.6618 Remote Similarity NPD7874 Approved
0.6618 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6617 Remote Similarity NPD7871 Phase 2
0.6617 Remote Similarity NPD7870 Phase 2
0.6615 Remote Similarity NPD8150 Discontinued
0.6609 Remote Similarity NPD5058 Phase 3
0.6607 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6607 Remote Similarity NPD447 Suspended
0.6607 Remote Similarity NPD5124 Phase 1
0.6606 Remote Similarity NPD4908 Phase 1
0.6605 Remote Similarity NPD2982 Phase 2
0.6605 Remote Similarity NPD4749 Approved
0.6605 Remote Similarity NPD2983 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data